GBI's China Antibodies report provides the essential starting point for managers, scientists, and entrepreneurs interested in understanding China's antibody industry. This report offers a comprehensive overview and analysis of China’s antibody industry together with a directory of more than 30 antibody-related enterprises. Detailed case studies and profiles of companies are included with information such as company size, customer segments, and executive profiles. This report includes cost data and addresses large-scale manufacturing.

Published: April 2007 | 42 Pages | Online Database

GBI's China BioServices report is an essential resource for biotechnology and pharmaceutical companies aiming to increase R&D productivity and reduce costs through outsourcing to China's bio-services companies. This fully updated report includes industry analysis and provides information on 74 Chinese and joint venture biotech service firms, case studies, and company profiles on selected leaders. This report will benefit pharmaceutical and biotechnology companies, bio-services companies, biotech tool suppliers, investors, and others requiring information concerning biotech services in China.

Published: May 2006 | 90 Pages | Online Database

GBI's China Pharmaceutical & Biotechnology Monthly is the intelligent guide to China’s healthcare industry. Filled with news, analysis, and coverage of the financial markets, CPB Monthly is essential for professionals and managers serious about tracking the opportunities and challenges China presents. Its contents include top stories, key facts and figures, news in general, policy and regulations, investments and finance, company, trade, research & development and IP & legal. It also has two company profiles and equity market review.

Published: Monthly

GBI's China Biotech 2008 report provides an in depth look at biotechnology R&D in China, with industry statistics and indicators and an authoritative directory of biotechnology companies. This report is essential for understanding China's emerging innovators, identifying potential clients and partners, and staying abreast of developments in this dynamic industry. This comprehensive directory includes companies applying biotechnology in industrial, agricultural, new drug development, and various bio-services sectors, as well as manufacturers of life science related tools and supplies. Each company listing contains pertinent contact information and also details product lines and services offered.

Published: January 2008 | 88 Pages | Online Database

GBI's China Vaccine report provides an in depth analysis of the human use vaccine industry and market in China. The markets analysis covers the private payer sector, as well as providing an in depth look at the National Immunization Program, and the impact of the 10-fold increase in budget announced in 2007. Industry coverage includes profiles and analysis of the major domestic companies and research institutes.

Published: December 2007 | 72 Pages | Oline Database

Molecular diagnostics in a high growth, high profit, high investment area in China. Industry players, investors, buyers, and vendors will benefit from this essential database. This database includes more than 100 companies providing molecular diagnostic products and services in China. More than 50 Chinese domestic and multinational kit & instrument manufacturers are included. The database also includes key distributors and service providers. Method of information collection: secondary research targeting company domain, public domain and government resources was conducted. This was followed by a primary phase including contact of more than 60% of companies in the database, and discussions with industry insiders.

Published: January 2008 | 80 Pages | Online Database

China's pharmaceutical companies are rapidly gaining prominence in the global market. With strong distribution channels within China, many exporting API, and many with shares floating on the US, Shanghai and other stock markets, Chinese pharmaceutical companies are poised to take a greater share of the global market. GBI's China Pharmaceutical Profiles report includes detailed case studies of 20 of China's leading players and provides insights into their operations, strengths and weaknesses, product portfolios, and investment performance.

Published: June 2007 | 100 Pages